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Abstract
Background Low mixed or central venous saturation (S(c)vO2)
can reveal global tissue hypoxia and therefore can predict poor
prognosis in critically ill patients. Early goal directed therapy
(EGDT), aiming at an ScvO2 ≥ 70%, has been shown to be a
valuable strategy in patients with sepsis or septic shock and is
incorporated in the Surviving Sepsis Campaign guidelines.
Methods In this prospective observational multi-center study,
we determined central venous pressure (CVP), hematocrit, pH,
lactate and ScvO2 or SvO2 in a heterogeneous group of critically
ill patients early after admission to the intensive care units (ICUs)
in three Dutch hospitals.
Results Data of 340 acutely admitted critically ill patients were
collected. The mean SvO2 value was > 65% and the mean
ScvO2 value was > 70%. With mean CVP of 10.3 ± 5.5 mmHg,
lactate plasma levels of 3.6 ± 3.6 and acute physiology, age and
chronic health evaluation (APACHE II) scores of 21.5 ± 8.3, the
in-hospital mortality of the total heterogeneous population was
32.0%. A subgroup of septic patients (n = 125) showed a CVP
of 9.8 ± 5.4 mmHg, mean ScvO2 values of 74.0 ± 10.2%, where
only 1% in this subgroup revealed a ScvO2 value < 50%, and
lactate plasma levels of 2.7 ± 2.2 mmol/l with APACHE II scores
20.9 ± 7.3. Hospital mortality of this subgroup was 26%.
Conclusion The incidence of low ScvO2 values for acutely
admitted critically ill patients is low in Dutch ICUs. This is
especially true for patients with sepsis/septic shock.
Background
Global tissue hypoxia as a result from systemic inflammatory
response or circulatory failure is an important indicator of
shock preceding multiple organ dysfunction syndrome
(MODS). The development of MODS predicts outcome of the
septic patient [1]. Unrecognized and untreated global tissue
hypoxia increases morbidity and mortality. Accurate detection
of global tissue hypoxia is therefore of vital importance. Physi-
cal findings, vital signs, measuring central venous pressure
(CVP) and urinary output are of the utmost importance, but not
always sufficient for accurate detection of global tissue
hypoxia [2,3].
It is now generally accepted that a decreased central venous
oxygen saturation (ScvO2) obtained from a central venous
catheter, can reveal a mismatch between oxygen supply and
oxygen demand, hence global tissue hypoxia [1]. Decreased
values predict poor prognosis after cardiovascular surgery [4],Page 1 of 6
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genic shock [6,7]. ScvO2 and SvO2 (mixed venous oxygen sat-
uration) can therefore be used as hemodynamic goals during
resuscitation. According to Rivers et al. [8], hemodynamic
optimization demands 'early goal-directed therapy' (EGDT),
including ScvO2-guided treatment. It was concluded that goal-
oriented manipulation of cardiac preload, afterload and con-
tractility, to achieve a balance between systemic oxygen deliv-
ery and oxygen demand, is a valuable strategy in patients with
sepsis or septic shock during the resuscitation period in the
emergency department (ED) [8]. More recently, as a result of
this study, an EGDT treatment protocol was included in the
'Surviving Sepsis Campaign' guidelines [1]. Also, several stud-
ies on implementation of such a protocol, partially in combina-
tion with other recommendations, have been published over
the last years [9-11].
Based on clinical experience it seemed that the syndrome tar-
geted in the EGDT study [8] was not very common in intensive
care units (ICUs) in The Netherlands, and thus EGDT was not
commonly indicated. The main purpose of this study was to
determine the incidence of low ScvO2 values in our geograph-
ical setting. We monitored a heterogeneous group of critically
ill patients during unplanned admission in three Dutch multi-
disciplinary ICUs. Also, illustratively, we compared the sub-
group of septic patients with the population of septic patients




We studied ICU populations in one academic ICU (the Aca-
demic Medical Center (AMC) in Amsterdam, The Netherlands)
and two non-academic ICUs (Gelre Hospital (GH) location
Lukas, in Apeldoorn, The Netherlands; Medical Center Leeu-
warden (MCL) in Leeuwarden, The Netherlands). The AMC is
a large teaching hospital where the ICU is a 28-bed 'closed
format' department in which medical/surgical patients, includ-
ing cardiothoracic and neurosurgical patients, are being
treated. GH is an affiliated teaching hospital where the ICU is
a 10-bed 'closed format' department. MCL is a large general
teaching hospital in the north of The Netherlands, with a 14-
bed 'closed format' mixed medical/surgical ICU, including car-
diothoracic patients.
Patients and data collection
Between January 2006 and March 2007 a total of 340
patients, all 18 years or older, with a clinical indication for a
central venous catheter (CVC) (BD Medical Systems, Singa-
pore), pulmonary artery catheter (PAC) (Edwards Lifesciences
LLC, Irvine, CA, USA) or Continuous Cardiac Output (CCO)
catheter that measures SvO2 continuously (Arrow Deutsch-
land GmbH, Erding, Germany) were recruited. Indication for a
central venous, PAC or CCO catheter was left to the discre-
tion of the attending physician. The patients arrived into the
ICU either directly from the ED, from the general ward, or after
acute surgery with severe sepsis, septic shock or cardiogenic
shock, respiratory failure, central nervous problems, and other
acute conditions. In the EDs, there was no standardized pro-
tocol for hemodynamic treatment of septic patients. Fluid
resuscitation was mostly guided by blood pressure monitor-
ing. Inotropes were given scarcely at the study EDs. Intubation
in the ED was also uncommon. In the operating theatres no
ScvO2/SvO2 measurements took place, nor any kind of goal-
directed therapy implemented. All patients were treated
according to standard practice for the ICU. Exclusion criteria
were elective surgery and aged < 18 years. Collection of data
for observational study without informed consent was
approved by the Medical Ethics Committees of all three
hospitals.
Measurements of systolic arterial pressure (SAP), mean arte-
rial pressure (MAP) and central venous pressure (CVP) were
recorded immediately after arrival into the ICU. Hematocrit
(Hct), lactate plasma levels and pH were determined from the
first obtained arterial blood sample in the ICU.
Acute physiology, age and chronic health evaluation
(APACHE) II score [12] and sequential organ failure assess-
ment (SOFA) score [13] at the time of admission into the ICU
were also collected.
Statistical analysis
The statistical package SPSS 15.0.1 for Windows (SPSS
Inc., Chicago, IL, USA)) was used for statistical analysis. All
data were tested for normal distribution with the Kolmogorov-
Smirnov test before further statistical analysis. Differences
between populations were assessed using the Student's
paired t test (normally distributed data). Data were displayed




A heterogeneous population with a total of 340 critically ill
patients was evaluated in the three participating ICUs (Table
1). The patients arrived into the ICU either directly from the ED
(n = 135; 40%), from the general ward (n = 126; 37%) or after
acute surgery (n = 79; 23%). To determine ScvO2 or SvO2 val-
ues, central venous or mixed venous oxygen saturation was
measured as early as possible after insertion of a central
venous catheter (n = 263) or pulmonary artery/CCO catheter
(n = 77). The vast majority (93%) of the patients were enrolled
within 6 h after presentation in the ER. More than 99% of all
the data was obtained within 2 h after ICU admission. The
numbers of measurements of central or mixed oxygen venous
saturation were not normally distributed between the three
ICUs. In all three hospitals the mean SvO2 was higher than
65% and mean ScvO2 was higher than 70%. Overall in-hospi-
tal mortality of our population was 32.0%.Page 2 of 6
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trally (Table 2). Mean ScvO2 was 72.0 ± 12.3%. A total of 38
patients (14%) had a ScvO2 < 60%, and only 14 (5%)
patients had a ScvO2 < 50%. While only a single patient of the
latter group was in septic shock, in-hospital mortality of these
14 patients was 57% (8/14).
Septic patients
In patients with sepsis or septic shock (n = 150) central
venous oxygen was measured in 125 patients and mixed
venous oxygen saturation was measured in 25 patients. The in-
hospital mortality of our septic patients was 27%. A total of 73
patients arrived in the ICU from general wards (49%). The
mean ScvO2 value was normal: 74.0 ± 10.2%. Only eight
(6%) patients had a ScvO2 < 60%, and one (1%) < 50%
(Table 2).
Comparison with the EGDT population
Compared to the Rivers study group our septic patients
revealed a significantly higher ScvO2 (74.0 ± 10.2 vs 48.9 ±
12.3%; p < 0.01), lower lactate plasma levels (2.7 ± 2.2 vs 7.3
± 4.6 mmol/l; p < 0.01), and lower hematocrit (30.3 ± 6.9 vs
34.7 ± 8.5%; p < 0.01). A total of 83% of patients needed
endotracheal intubation versus 55% in the EGDT study [8].
APACHE II scores were equal (20.9 ± 7.0 vs 20.9 ± 7.2; p =
1.0). The in-hospital mortality of this subgroup was 26%
(Table 2).
Table 1
Distribution of clinical problems in the three ICUs
Admission diagnosis MCL (n = 93) GH (n = 138) AMC (n = 109) Total (n = 340)
Sepsis/septic shock 47 (51) 64 (46) 39 (36) 150 (44)
Cardiac failure, cardiac arrest 28 (30) 10 36 (26) 10 31 (28) 17 95 (28)
Respiratory failure 7 (8) 13 (10) 12 (11) 32 (9)
CNS 5 (5) 7 (5) 10 (9) 22 (7)
Other 6 (6) 18 (13) 17 (12) 41 (12)
Data are presented as numbers (%). AMC, Amsterdam Medical Center; CNS, central nervous system; GH, Gelre Hospital; ICU, Intensive Care 
Unit; MCL, Medical Center Leeuwarden.
Table 2
Demographic data, variables and outcome data; comparisons of sepsis patients with EGDT study [8] data
Variable Present cohort (n = 263) Sepsis (n = 125) EGDT study (n = 263) p Valuea,b
Age (years) 67.3 ± 14.2 68.9 ± 13.5 65.7 ± 17.2 0.01*
Female (%) 41 38 49.4
Male (%) 59 62 50.6
Heart rate (beats/min) 107 ± 27 115 ± 26 115 ± 29 1.0
CVP (mmHg) 9.8 ± 5.4 10.8 ± 4.9 5.7 ± 8.5 < 0.01*
MAP (mmHg) 58 ± 16 60 ± 13 75 ± 25 < 0.01*
ScvO2 (%) 72.0 ± 12.3 74.0 ± 10.2 48.9 ± 12.3 < 0.01*
Lactate (mmol/l) 3.3 ± 3.3 2.7 ± 2.2 7.3 ± 4.6 < 0.01*
Arterial pH 7.33 ± 0.12 7.35 ± 0.10 7.32 ± 0.18 0.42
Hematocrit (%) 31.0 ± 7.0 30.3 ± 6.9 34.7 ± 8.5 < 0.01*
APACHE II score 21.5 ± 8.5 20.9 ± 7.3 20.9 ± 7.2 1.0
SOFA score 9.5 ± 3.6 9.6 ± 3.0
In-hospital mortality (%) 31.0 26.0
Standard therapy 46.5
EGDT 30.5
Data are presented as means ± SD. aUnpaired t test; bsepsis subgroup vs EGDT study. *Statistically significant difference. APACHE II, Acute 
Physiology, Age and Chronic Health Evaluation; CVP, central venous pressure; EGDT, early goal-directed therapy; MAP, mean arterial pressure; 
ScvO2, central venous oxygen saturation; SOFA, Sequential Organ Failure Assessment.Page 3 of 6
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Measurement of mixed venous oxygen saturation took place in
77 patients. Mean SvO2 was 68.2 ± 11.8%. Mean lactate was
4.3 ± 4.2 mmol/l; arterial pH was 7.30 ± 0.11. With mean
APACHE II scores of 21.8 ± 7.3 and mean SOFA scores of
9.3 ± 3.6, the in-hospital mortality was 37% (Table 3).
Of the 25 patients in whom mixed venous oxygen saturation
was measured in the subgroup of septic patients, four (16%)
patients showed a SvO2 value < 60% on admission. One
patient (4%) had a SvO2 < 50%. In this relatively small sub-
group, mean Hct was 28.2 ± 5.4%, mean MAP 61.0 ± 13.4
mmHg and mean CVP 13.7 ± 4.6 mmHg, while 80% (20/25
patients) needed mechanical ventilation. Mean APACHE II
score was 22.2 ± 5.4 and mean SOFA score10.3 ± 3.7. The
in-hospital mortality of this subgroup was 28% (Table 3).
Discussion
The main result of this present multi-center observational study
is the low incidence of low ScvO2 values (< 50%) in septic
patients being only 1%. Secondary findings were the normal
mean ScvO2 values and normal mean SvO2 values in critically
ill patients, including patients with severe sepsis or septic
shock, on admission in the three ICUs.
Development of severe sepsis and septic shock involves sev-
eral pathogenic changes, including global tissue hypoxia as a
result of circulatory abnormalities [14]. In particular, hemody-
namic optimization as a therapeutic target has been studied
over the last decade [2,8,9,15,16]. Based on promising
results from earlier studies [2], Rivers et al. randomized
patients with severe sepsis or septic shock to standard ther-
apy or EGDT. The latter resulted in an absolute reduction in
28-day mortality of 16% [8]. Improvement of the balance
between oxygen delivery (DO2) and oxygen demand (VO2)
played an important role. Other studies, however, found no
reduction of morbidity or mortality as a result of aggressive
hemodynamic optimization, despite higher central venous oxy-
genation or lower lactate concentrations [15,16]. Studies that
enrolled patients admitted into the ICU were unable to show a
decrease in mortality rate after aggressive hemodynamic opti-
mization [16,17], in contrast to studies that implemented
certain treatment protocols, including antibiotic therapy, in the
emergency department [8,9,11]. In this ICU study we found
mean ScvO2 and SvO2 values in the normal range. Similar fig-
ures are described previously in the later stage of sepsis and
in ICU patients [18,19]. This is in concordance with the
findings by Gattinoni et al. (67, 3–69, 7%) [15] and Bracht et
al. (70%) [20].
ScvO2 is a surrogate for SvO2: a significant correlation
between the two has been described [21]. Although it might
still be debatable whether central venous and mixed venous
oxygen saturation are equivalent or not [18,19,21], the clinical
importance of both measurements seems not to be an issue.
The Surviving Sepsis Campaign recognizes such in the resus-
citation portion of its severe sepsis and septic shock informa-
tion [1]. Our study design does not allow for any statistical
evaluation of ScvO2 compared to SvO2.
APACHE II scores were similar in comparison to the popula-
tion described in the EGDT study [8]. This suggests equal
mortality rate predictions. However, physiological scores such
as APACHE II are dependent on variables that reflect the pro-
gression or reversal of organ dysfunction. Treatment in the ED
or operating theatre prior to ICU admission influences calcula-
tion of the physiological scores. Consequently, the physiolog-
ical scores at our ICUs could partially be underestimated. The
significantly higher lactate plasma levels in the EGDT study
suggest a more severe tissue hypoperfusion in that group.
However, it is the clearance rate that is associated with less
organ failure and improved survival [22].
Unlike significantly lower mean arterial pressures, the higher
CVP and the lower hematocrit suggest that the septic patients
were less hypovolemic compared to the EGDT population.
Relatively high mean blood pressure in the EGDT population
suggests an earlier stage of sepsis with predominating vaso-
constriction, or pre-existing hypertension. The higher CVP in
the subgroup with septic patients (n = 125) is partially the
result of high percentage of endotracheal intubation and thus
increased intrathoracic pressure before measurement (83%).
In the EGDT study, less than 55% needed intubation at
admission.
Table 3
Demographic data, variables and outcome data; mixed venous 
saturations
Variable Present cohort (n = 77) Sepsis (n = 25)
Age (years) 61.7 ± 14.0 65.4 ± 10.4
Female (%) 39 52
Male (%) 61 48
Heart rate (beats/min) 102 ± 21 102 ± 21
CVP (mmHg) 13.0 ± 4.9 13.7 ± 4.6
MAP (mmHg) 61 ± 15 61 ± 13
SvO2 (%) 68.2 ± 11.8 72.1 ± 10.8
Lactate (mmol/l) 4.3 ± 4.2 3.3 ± 2.3
Arterial pH 7.30 ± 0.11 7.32 ± 0.08
Hematocrit (%) 29.9 ± 7.1 28.2 ± 5.4
APACHE II score 21.7 ± 7.3 22.2 ± 5.4
SOFA score 9.3 ± 3.6 10.3 ± 3.7
In-hospital mortality (%) 37.0 28.0
Data are presented as means ± SD. APACHE II, Acute Physiology, 
Age and Chronic Health Evaluation; CVP, central venous pressure; 
MAP, mean arterial pressure; SOFA, Sequential Organ Failure 
Assessment; SvO2, mixed venous oxygen saturation.Page 4 of 6
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Available online http://ccforum.com/content/12/2/R33As mentioned earlier, in the present study the patients were
treated in the ED, or elsewhere, before admission to the ICU.
This treatment was different from the treatment given in the
EGDT study. Nevertheless, our patients received some fluid
therapy. Transfusion of red blood cells in our EDs was based
on clinical suspicion or evidence of severe blood loss and not
on low hematocrit only. Also, a main principle of treatment is to
improve oxygen delivery and this could contribute to higher
ScvO2 values in the ICU population compared to the patients
described in the EGDT study and other ED studies. Other
interventions such as sedation and analgesia, most often to
facilitate endotracheal intubation and ventilation, might have
been beneficial for the balance between oxygen delivery and
oxygen demand. Also, the trend of changing ScvO2 and other
physiological values influencing outcome [23,24] is not taken
into account in our study. Of course, all these factors are
important differences between ER populations and ICU popu-
lations, but are not predominating. We are aware that compar-
ison between those populations is limited by the above-
mentioned differences.
As a result of the study design, statements about cut-off
S(c)vO2 values for outcome prediction [20,24] or impact on
therapeutic intervention are not possible. Also, we did not
investigate the use of vital signs as indicator of tissue oxygen-
ation in comparison to mixed or central venous saturation.
Lack of clear insight of treatment and time spent at the differ-
ent EDs, operating theatres or wards is a limitation of our study
as well. Nevertheless, since we also aimed at the usefulness
of measuring ScvO2 or SvO2 on ICU admission, we think these
factors are not pertinent to the results. For example, Bracht et
al. [20] found no correlation between ScvO2 values and length
of hospital stay before unplanned ICU admission.
Comparing our sepsis population with the ED population
described in the important study by Rivers [8] is meant to be
purely illustrative. Obviously, as we described, there are differ-
ences between ED and ICU populations in general. But there
are also, depending on geographical setting, important differ-
ences between populations and health care systems. There-
fore, we subscribe to the view of Ho et al. [25] that the
syndrome described in the EGDT trial may be relatively
uncommon depending on geographical setting and health
care system. However, this does not undermine the impor-
tance of early identification of patients at high risk for cardio-
vascular collapse. For example, in our study of the 14 patients
with a ScvO2 < 50%, the in-hospital mortality was 57%.
Finally, the in-hospital mortality in our study was 32.0% for the
total population and 27.0% for the patients with severe sepsis
or septic shock. Again this reflects recent findings by others:
Ho et al. (30.2%) [25] and Shapiro et al. (26.9%) [26].
Conclusion
In conclusion, the incidence of low ScvO2 values for acutely
admitted critically ill patients is low in Dutch ICUs. This is
especially true for patients with sepsis/septic shock.
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